Frequently Asked Questions
Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
1. HCV SPOT
Hepatitis C is a viral infection that primarily affects the liver and can cause both acute and chronic disease.
Anyone at risk of hepatitis C exposure or needing routine screening should undergo this test. This includes individuals with potential exposure through unsafe injection practices, blood transfusions before 1992, and other high-risk behaviors.
Yes, the HCV Spot Test is highly accurate in detecting antibodies against hepatitis C virus. However, a positive result requires confirmation through additional tests.
No, additional tests are needed to differentiate between acute and chronic hepatitis C infection.
A positive result indicates possible hepatitis C infection. Further confirmatory tests and counseling will be provided to determine the next steps for treatment and care.
2. What are the risks of endovascular surgery?
Risks may include bleeding, infection, blood clots, or damage to blood vessels. However, the minimally invasive nature of the procedure reduces these risks.
3. ANTI HBSAG
It is a test that detects antibodies against the Hepatitis B surface antigen (HBsAg) to assess immunity to Hepatitis B.
It is recommended after Hepatitis B vaccination, recovery from Hepatitis B, or as part of routine screening.
No special preparation is required. Inform your healthcare provider of any recent vaccinations or Hepatitis B history.
Results are usually available within 24 to 48 hours after the blood sample is collected.
Positive results indicate immunity to Hepatitis B, while negative results may suggest the need for further evaluation or vaccination.